Skip to main content
. 2022 Apr 4;10(7):2271–2284. doi: 10.1002/fsn3.2836

TABLE 2.

Effects of CCl4, LmPS, and their combination (LmPS/CCl4) on hepatic serum markers of control and experimental rats

Treatment AST ALT ALP LDH
C 160 ± 3.75 40.55 ± 7.6 60.25 ± 7.4 890 ± 85
CCl4 230.9 ± 14.2 *** 93.33 ± 10.32** 95.33 ± 10.86** 1,350 ± 135***
LmPS/CCl4 156 ± 5.7## 37.7 ± 9.3## 58.4 ± 6.8### 885.55 ± 78.33###
LmPS 157 ± 5.9 39 ± 3.6 60.33 ± 1.6 887 ± 90.33

Values are mean ± SEM for eight rats in each group. CCl4, LmPS, and LmPS/CCl4‐treated groups versus control group; **,## p < .01, ***,### p < .001, CCl4 group versus (LmPS/CCl4).